Non-interventional Observational Study With Viramune Plus Antiretroviral Backbone Combination in HIV-infected Women and Male Patients. Gender Specific Evaluation of Data
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2015
At a glance
- Drugs Nevirapine (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 10 Jun 2017 Biomarkers information updated
- 10 Jan 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 06 Mar 2013 Planned end date changed from 1 Mar 2015 to 1 Dec 2013 as reported by ClinicalTrials.gov.